CAW
BLUE

Cornerstone Advisors (Washington)’s bluebird bio BLUE Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26
Closed -$43K – 906
2019
Q2 		$43K Sell
26
-1
-4% -$1.73K ﹤0.01% 438
2019
Q1 		$56K Buy
27
+2
+8% +$3.52K 0.01% 327
2018
Q4 		$33K Buy
25
+23
+1,150% +$35.3K 0.01% 396
2018
Q3 		$3K Buy
+2
New +$4.13K ﹤0.01% 816

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Cornerstone Advisors (Washington)'s BLUE Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 26 shares — an estimated $43K sold.

Cornerstone Advisors (Washington) first reported a position in BLUE in Q3 2018 and held it in 4 quarters. The position peaked at $56K in Q1 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 26 bluebird bio shares in Q3 2019, an estimated $43K.
  • Cornerstone Advisors (Washington) first reported a position in bluebird bio in Q3 2018 and held it in 4 quarters.
  • Cornerstone Advisors (Washington)'s bluebird bio position peaked at $56K in Q1 2019.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.